Cantargia AB 2024 SR
The report outlines Cantargia's sustainability strategy and performance for 2024, focusing on its commitment to developing pharmaceuticals for cancer and inflammatory diseases. Key highlights include alignment with UN SDGs 3, 5, 8, 9, and 13, and a reduction in average CO2 emissions per employee from business travel by 12.9%. The company also reports on energy and water consumption at its LEED Platinum-certified premises and provides data on gender distribution within its workforce and Board of Directors.
Company: Cantargia AB
Sector: Professional & technical services
Country: Sweden
Year: 2024
Type: SR
Pages: 5
Back to company
Cantargia AB
Sustainability Report
The report outlines Cantargia's sustainability strategy and performance for 2024, focusing on its commitment to developing pharmaceuticals for cancer and inflammatory diseases. Key highlights include alignment with UN SDGs 3, 5, 8, 9, and 13, and a reduction in average CO2 emissions per employee from business travel by 12.9%. The company also reports on energy and water consumption at its LEED Platinum-certified premises and provides data on gender distribution within its workforce and Board of Directors.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2024
Reporting Period
2024
Fiscal Year
2024
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Sustainable Development Goals
Other Standards
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Energy Consumption
Water Consumption
Women on Board
Women in Management
Employees